[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Covid could have started earlier than thought", "description": "Just when did the covid virus start spreading around the world?\n\nSenator\u2019s report on viral origins\n\n(Richard Burr)\n\nhttps://www.help.senate.gov/imo/media/doc/report_an_analysis_of_the_origins_of_covid-19_102722.pdf\n\nSection III\n\nChina\u2019s early COVID-19 Vaccine Development versus the U.S. Operation Warp Speed \n\nFull genetic sequence, SARS-CoV-2\n\nFirst posted, global virus database, January 11, 2020\n\nChinese professor, violated government restrictions\n\nThen\n\nVaccine developers inserted viral genome into cells to produce viral proteins\n\nPreclinical animal toxicity \n\nSafety and efficacy studies \n\nHuman clinical safety and efficacy trials\n\nCommercial scale vaccine production. \n\nOperation Warp Speed\n\nPre OWS work started on January 11, 2020\n\nE.g. Adenovirus vector vaccines\n\nThe AstraZeneca-Oxford, went from sequence to phase I clinical trials in 103 days\n\n(Ebola platform)\n\nJ and J was 185 days\n\nThree adenovirus vector vaccines\n\nPfizer trail started 7th May 2020\n\nAnother Chinese vaccine was patented on 24th February 2020 \n\n(Brigadier General Yusen Zhou, Academy of Military Medical Sciences)\n\nQuestion\n\nDid Chinese researchers have access to the genomic sequence before January 11, 2020? \n\nIf so, how far in advance of January 11, 2020?\n\n\nMEP Cristian Terhes\n\nhttps://www.youtube.com/watch?v=2jTgDj7uiX8\n\nIn the case of Pfizer\n\nSubmitted a clinical trial that started in 14th January 2020\n\nThree days later Pfizer already started a test for these vaccines\n\nModerna\n\nTrials since 2017\n\nhttps://www.modernatx.com/en-US/about-us/our-story\n \nhttps://apnews.com/article/fact-checking-161756112404\n\nhttps://www.riotimesonline.com/wp-content/uploads/2022/02/Moderna-Patent-US9587003-B2.pdf\n\nhttps://patentimages.storage.googleapis.com/01/6e/60/8951ab8f4118b5/US9587003.pdf\n\nVirus shares a sequence of 19 nucleotides with Moderna genome\n\nPart of spike protein\nCoincidence or not a coincidence?\n\n(Adenine, Cytosine, Guanine, Uracil)", "link": "https://www.youtube.com/watch?v=7DwIfrFbyuI", "date_published": "2022-11-01 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "US Senate, lab origin most likely", "description": "Senate report on COVID coronavirus origins\n\nthe emergence of SARS-CoV-2 that resulted in the COVID-19 pandemic was most likely the result of a research-related incident\n\nhttps://www.help.senate.gov/imo/media/doc/report_an_analysis_of_the_origins_of_covid-19_102722.pdf\n\nDec. 20, 2019 to Jan. 18, 2020\n\nSearches for flu-like symptoms \n\nCases probably started mid October, 2019\n\nAnalysis of Natural Zoonotic Origins Hypothesis \n\nSevere Acute Respiratory Syndrome (SARS)\n\nMiddle East Respiratory Syndrome (MERS) \n\nLack of intermediate bats to humans\n\nVirus likely needed to circulate in an intermediate host\n \nAn animal virus must evolve to gain human infecting potential\n\nClosest virus is in horseshoe bats residing in Southern China or Southeast Asia\n \nEpidemiology of SARS-CoV-2 Outbreak Differs from Previous Natural Zoonotic Spill overs \n\nLack of dead ends spill over events, no epidemiological train in animals or humans\n\nInfluenza\n\nInfected poultry and birds always found\n\nH7N9 (2019) multiple independent introductions across multiple locations\n\nGeographically disparate, independent spill overs of H7N9 \n\nAvian Influenza\n\nhad circulated in bird populations, \n\ntime and several provinces in China before the first known human infections \n\nSARS epidemic\n\nAt least five independent spill overs of the SARS virus into humans\n\nLive animal markets followed by human to human\n\nE.g. Guangdong Province, November 2002 to January 2003\n\nSARS, later on in 2003 \u2013 2004\n\nAdditional independent subsequent spill over infections in humans\n\nCivets identified within 6 months\n\nEarly SARS viral samples from humans contained genetic mutations that reflected prior circulation and adaptation in palm civets \n\nIn total contrast\n\nChinese government, asserted that the COVID-19 originated from a natural zoonotic transmission occurring at the Huanan market\n\nGeo-temporal spread of COVID-19 in China, December 31, 2019 to February 11, 2020\n\nEarliest identified SARS-CoV-2 well-adapted for human-to-human transmission \n\nEarly SARS-CoV-2 variants had little genetic diversity, 2 nucleotides out of 29,900\n\n(Adenine, Cytosine, Guanine, Uracil)\n\nNo evidence of previous intermediate host circulation\n\nGenetic similarity between the environmental samples and human viral samples,\n\nsupports the likelihood that the virus found at the Huanan Seafood Market was shed by humans\n\nHealth, Education, Labor and Pensions (HELP) Committee, \n\nto address pandemic preparedness and response programs\n\nInterim report, to examine the two prevailing theories of origin\n\nLast fifteen months\n\nReviewed several hundred scientific studies, \n\ninterviewed several dozen subject matter experts, \n\nanalyzed previous reports and studies.\nThe lack of transparency and collaboration from government and public health officials in the People\u2019s Republic of China with respect to the origins of SARS-CoV-2 prevents reaching a more definitive conclusion. \n\nI hope this report will guide the World Health Organization and other international institutions\n\nIntroduction\n\nChallenging\n\nSince January 3, 2020,\n \nPeople\u2019s Republic of China (PRC) have prohibited sharing or publishing any information on SARS-CoV-2 without state review and approval. \n\nEstablishing timeline, is difficult\n\nMid October, 2019", "link": "https://www.youtube.com/watch?v=EaJt5jC5gbY", "date_published": "2022-10-31 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]